• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用深入采样 HIV 分子网络在非 B 型流行地区确定优先干预目标。

Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area.

机构信息

NHC Key Laboratory of AIDS Immunology (China Medical University), National Clinical Research Center for Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, China.

Laboratory Medicine Innovation Unit, Chinese Academy of Medical Sciences, Shenyang, China.

出版信息

Front Cell Infect Microbiol. 2021 Mar 29;11:642903. doi: 10.3389/fcimb.2021.642903. eCollection 2021.

DOI:10.3389/fcimb.2021.642903
PMID:33854982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8039375/
Abstract

Molecular network analysis based on the genetic similarity of HIV-1 is increasingly used to guide targeted interventions. Nevertheless, there is a lack of experience regarding molecular network inferences and targeted interventions in combination with epidemiological information in areas with diverse epidemic strains of HIV-1.We collected 2,173 sequences covering 84% of the total newly diagnosed HIV-1 infections in Shenyang city, Northeast China, between 2016 and 2018. Molecular networks were constructed using the optimized genetic distance threshold for main subtypes obtained using sensitivity analysis of plausible threshold ranges. The transmission rates (TR) of each large cluster were assessed using Bayesian analyses. Molecular clusters with the characteristics of ≥5 newly diagnosed cases in 2018, high TR, injection drug users (IDUs), and transmitted drug resistance (TDR) were defined as priority clusters. Several HIV-1 subtypes were identified, with a predominance of CRF01_AE (71.0%, 1,542/2,173), followed by CRF07_BC (18.1%, 393/2,173), subtype B (4.5%, 97/2,173), other subtypes (2.6%, 56/2,173), and unique recombinant forms (3.9%, 85/2,173). The overall optimal genetic distance thresholds for CRF01_AE and CRF07_BC were both 0.007 subs/site. For subtype B, it was 0.013 subs/site. 861 (42.4%) sequences of the top three subtypes formed 239 clusters (size: 2-77 sequences), including eight large clusters (size 10 sequences). All the eight large clusters had higher TR (median TR = 52.4/100 person-years) than that of the general HIV infections in Shenyang (10.9/100 person-years). A total of ten clusters including 231 individuals were determined as priority clusters for targeted intervention, including eight large clusters (five clusters with≥5 newly diagnosed cases in 2018, one cluster with IDUs, and two clusters with TDR (K103N, Q58E/V179D), one cluster with≥5 newly diagnosed cases in 2018, and one IDUs cluster. In conclusion, a comprehensive analysis combining in-depth sampling HIV-1 molecular networks construction using subtype-specific optimal genetic distance thresholds, and baseline epidemiological information can help to identify the targets of priority intervention in an area epidemic for non-subtype B.

摘要

基于 HIV-1 遗传相似性的分子网络分析越来越多地被用于指导靶向干预。然而,在 HIV-1 流行株多样的地区,缺乏关于分子网络推断和结合流行病学信息的靶向干预的经验。

我们收集了 2016 年至 2018 年间在中国东北地区沈阳市新诊断的 HIV-1 感染患者的 2173 个序列,涵盖了总感染患者的 84%。使用合理阈值范围内的敏感性分析来优化主要亚型的遗传距离阈值,然后构建分子网络。使用贝叶斯分析评估每个大簇的传播率(TR)。将 2018 年新诊断病例≥5 例、TR 较高、注射吸毒者(IDU)和传播耐药(TDR)的分子簇定义为优先干预簇。

确定了几种 HIV-1 亚型,其中以 CRF01_AE(71.0%,1542/2173)为主,其次是 CRF07_BC(18.1%,393/2173)、B 亚型(4.5%,97/2173)、其他亚型(2.6%,56/2173)和独特重组形式(3.9%,85/2173)。CRF01_AE 和 CRF07_BC 的最佳遗传距离阈值均为 0.007 个替代/位点。B 亚型的最佳遗传距离阈值为 0.013 个替代/位点。前三种亚型的 861 个(42.4%)序列形成了 239 个簇(大小为 2-77 个序列),包括 8 个大簇(大小为 10 个序列)。所有 8 个大簇的传播率(TR)都高于沈阳市一般 HIV 感染(10.9/100 人年)(中位数 TR=52.4/100 人年)。共有 10 个包括 231 个个体的簇被确定为靶向干预的优先簇,包括 8 个大簇(2018 年新诊断病例≥5 例的 5 个簇、1 个 IDU 簇和 2 个 TDR(K103N、Q58E/V179D)簇、2018 年新诊断病例≥5 例的 1 个簇和 1 个 IDU 簇)。

总之,结合深入采样、使用亚型特异性最佳遗传距离阈值构建分子网络和基线流行病学信息的综合分析,可以帮助确定非 B 亚型流行地区的优先干预目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b1/8039375/177ac1101100/fcimb-11-642903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b1/8039375/98178c1038b8/fcimb-11-642903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b1/8039375/177ac1101100/fcimb-11-642903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b1/8039375/98178c1038b8/fcimb-11-642903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1b1/8039375/177ac1101100/fcimb-11-642903-g002.jpg

相似文献

1
Priority Intervention Targets Identified Using an In-Depth Sampling HIV Molecular Network in a Non-Subtype B Epidemics Area.使用深入采样 HIV 分子网络在非 B 型流行地区确定优先干预目标。
Front Cell Infect Microbiol. 2021 Mar 29;11:642903. doi: 10.3389/fcimb.2021.642903. eCollection 2021.
2
HIV-1 drug resistance and genetic transmission network among newly diagnosed people living with HIV/AIDS in Ningbo, China between 2018 and 2021.2018 年至 2021 年期间中国宁波新诊断的艾滋病毒感染者/艾滋病患者中 HIV-1 耐药性和遗传传播网络。
Virol J. 2023 Oct 13;20(1):233. doi: 10.1186/s12985-023-02193-x.
3
Molecular Network Analysis Reveals Transmission of HIV-1 Drug-Resistant Strains Among Newly Diagnosed HIV-1 Infections in a Moderately HIV Endemic City in China.分子网络分析揭示了中国一个中度艾滋病毒流行城市新诊断的艾滋病毒-1感染中艾滋病毒-1耐药菌株的传播情况。
Front Microbiol. 2022 Jan 7;12:797771. doi: 10.3389/fmicb.2021.797771. eCollection 2021.
4
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018.2016 年至 2018 年期间中国东北地区沈阳市新诊断 HIV 感染者中替诺福韦/恩曲他滨耐药的传播。
BMC Infect Dis. 2021 Jul 9;21(1):668. doi: 10.1186/s12879-021-06312-3.
5
Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021.2019年至2021年南京新诊断HIV-1感染的分子传播网络分析
BMC Infect Dis. 2024 Jun 12;24(1):583. doi: 10.1186/s12879-024-09337-6.
6
Genetic diversity and drug resistance among newly diagnosed and antiretroviral treatment-naive HIV-infected individuals in western Yunnan: a hot area of viral recombination in China.中国病毒重组热点地区——滇西地区新诊断且未经抗反转录病毒治疗的 HIV 感染者的遗传多样性和耐药性研究
BMC Infect Dis. 2012 Dec 28;12:382. doi: 10.1186/1471-2334-12-382.
7
Spatial clusters of HIV-1 genotypes in a recently infected population in Yunnan, China.中国云南新近感染人群中 HIV-1 基因型的空间聚集性。
BMC Infect Dis. 2019 Jul 29;19(1):669. doi: 10.1186/s12879-019-4276-9.
8
Molecular genetics and epidemiological characteristics of HIV-1 epidemic strains in various sexual risk behaviour groups in developed Eastern China, 2017-2020.2017-2020 年,中国东部发达地区不同性行为风险人群中 HIV-1 流行株的分子遗传学及流行病学特征。
Emerg Microbes Infect. 2022 Dec;11(1):2326-2339. doi: 10.1080/22221751.2022.2119167.
9
[Analysis on the transmission characteristics of newly reported human immunodeficiency virus/acquired immunodeficiency syndrome cases based on the molecular transmission network in Huzhou, Zhejiang, 2017].基于2017年浙江省湖州市分子传播网络的新报告人类免疫缺陷病毒/获得性免疫缺陷综合征病例传播特征分析
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Dec 6;53(12):1278-1283. doi: 10.3760/cma.j.issn.0253-9624.2019.12.014.
10
Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.中国7个城市男男性行为者中1型艾滋病毒感染者非CRF01_AE亚型中与逆转录酶(RT)相关的传播性耐药性增加。
J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):250-5. doi: 10.1097/QAI.0000000000000467.

引用本文的文献

1
Molecular transmission network analysis of newly diagnosed HIV-1 infections in Nanjing from 2019 to 2021.2019年至2021年南京新诊断HIV-1感染的分子传播网络分析
BMC Infect Dis. 2024 Jun 12;24(1):583. doi: 10.1186/s12879-024-09337-6.
2
Optimization of genetic distance threshold for inferring the CRF01_AE molecular network based on next-generation sequencing.基于下一代测序推断 CRF01_AE 分子网络的遗传距离阈值优化。
Front Cell Infect Microbiol. 2024 May 22;14:1388059. doi: 10.3389/fcimb.2024.1388059. eCollection 2024.
3
Exploring Dynamic Changes in HIV-1 Molecular Transmission Networks and Key Influencing Factors: Cross-Sectional Study.

本文引用的文献

1
Dynamics of HIV-1 Molecular Networks Reveal Effective Control of Large Transmission Clusters in an Area Affected by an Epidemic of Multiple HIV Subtypes.HIV-1分子网络动态揭示了在受多种HIV亚型流行影响地区对大型传播集群的有效控制。
Front Microbiol. 2020 Nov 13;11:604993. doi: 10.3389/fmicb.2020.604993. eCollection 2020.
2
The Central Role of Nondisclosed Men Who Have Sex With Men in Human Immunodeficiency Virus-1 Transmission Networks in Guangzhou, China.未公开身份的男男性行为者在中国广州人类免疫缺陷病毒1型传播网络中的核心作用
Open Forum Infect Dis. 2020 May 6;7(5):ofaa154. doi: 10.1093/ofid/ofaa154. eCollection 2020 May.
3
探索 HIV-1 分子传播网络的动态变化及关键影响因素:一项横断面研究。
JMIR Public Health Surveill. 2024 May 29;10:e56593. doi: 10.2196/56593.
4
Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.中国郑州市 ART 经验丰富的 HIV-1 低病毒血症患者耐药突变特征。
Sci Rep. 2024 May 9;14(1):10620. doi: 10.1038/s41598-024-60965-z.
5
Inferring potential non-disclosed men who have sex with men among self-reported heterosexual men with HIV in Southwest China: A genetic network study.在中国西南部,对自我报告的 HIV 阳性异性恋男性中潜在未公开的男男性行为者进行推断:一项遗传网络研究。
PLoS One. 2023 Mar 31;18(3):e0283031. doi: 10.1371/journal.pone.0283031. eCollection 2023.
6
Undiagnosed HIV Infections May Drive HIV Transmission in the Era of "Treat All": A Deep-Sampling Molecular Network Study in Northeast China during 2016 to 2019.未诊断的 HIV 感染可能会推动“治疗所有”时代的 HIV 传播:2016 年至 2019 年期间在中国东北地区进行的深度采样分子网络研究。
Viruses. 2022 Aug 27;14(9):1895. doi: 10.3390/v14091895.
7
Transmission and Drug Resistance Characteristics of Human Immunodeficiency Virus-1 Strain Using Medical Information Data Retrieval System.利用医学信息数据检索系统研究人类免疫缺陷病毒-1 株的传播和耐药特征。
Comput Math Methods Med. 2022 Jun 13;2022:2173339. doi: 10.1155/2022/2173339. eCollection 2022.
8
Molecular Network Analysis Reveals Transmission of HIV-1 Drug-Resistant Strains Among Newly Diagnosed HIV-1 Infections in a Moderately HIV Endemic City in China.分子网络分析揭示了中国一个中度艾滋病毒流行城市新诊断的艾滋病毒-1感染中艾滋病毒-1耐药菌株的传播情况。
Front Microbiol. 2022 Jan 7;12:797771. doi: 10.3389/fmicb.2021.797771. eCollection 2021.
9
The Establishment and Spatiotemporal History of A Novel HIV-1 CRF01_AE Lineage in Shenyang City, Northeastern China in 2002-2019.2002年至2019年中国东北沈阳市一种新型HIV-1 CRF01_AE谱系的建立及时空演变史
Virol Sin. 2021 Dec;36(6):1668-1672. doi: 10.1007/s12250-021-00435-2. Epub 2021 Aug 23.
Trend of HIV-1 drug resistance in China: A systematic review and meta-analysis of data accumulated over 17 years (2001-2017).
中国HIV-1耐药性趋势:对17年(2001 - 2017年)积累数据的系统评价和荟萃分析
EClinicalMedicine. 2020 Jan 5;18:100238. doi: 10.1016/j.eclinm.2019.100238. eCollection 2020 Jan.
4
The prevalence of HIV among MSM in China: a large-scale systematic analysis.中国男男性行为者中 HIV 的流行情况:一项大规模系统分析。
BMC Infect Dis. 2019 Nov 27;19(1):1000. doi: 10.1186/s12879-019-4559-1.
5
[National HIV/AIDS epidemic estimation and interpretation in China].[中国全国艾滋病病毒/艾滋病流行情况估计与解读]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Oct 10;40(10):1191-1196. doi: 10.3760/cma.j.issn.0254-6450.2019.10.004.
6
HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017.2011年至2017年中国四川接受抗逆转录病毒治疗但病毒学治疗失败的男男性行为者中的HIV-1亚型多样性、耐药性及基因传播网络
Medicine (Baltimore). 2019 Oct;98(43):e17585. doi: 10.1097/MD.0000000000017585.
7
BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis.BEAST 2.5:一个用于贝叶斯进化分析的高级软件平台。
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650. doi: 10.1371/journal.pcbi.1006650. eCollection 2019 Apr.
8
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and Quebec.对高危人群进行深入抽样,以描述在法国和魁北克使用暴露前预防(PrEP)的年轻男男性行为者中的艾滋病毒传播流行情况。
Open Forum Infect Dis. 2019 Feb 15;6(3):ofz080. doi: 10.1093/ofid/ofz080. eCollection 2019 Mar.
9
[Transmission cluster and network of HIV-1 CRF01_AE strain in China, 1996-2014].[1996 - 2014年中国HIV-1 CRF01_AE毒株的传播簇与传播网络]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Jan 10;40(1):84-88. doi: 10.3760/cma.j.issn.0254-6450.2019.01.017.
10
Identifying Clusters of Recent and Rapid HIV Transmission Through Analysis of Molecular Surveillance Data.通过分子监测数据分析识别近期和快速 HIV 传播簇。
J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):543-550. doi: 10.1097/QAI.0000000000001856.